List view / Grid view
11 June 2018 | By Sciex
New software offers improved workflow efficiency with enhanced data management and the tools to support 21 CFR Part 11 compliance across the SCIEX mass spectrometry portfolio...
7 June 2018 | By European Pharmaceutical Review
The EMA has recommended granting a marketing authorisation for Tegsedi, a medicine for the treatment of stage 1 or stage 2 polyneuropathy...
7 June 2018 | By European Pharmaceutical Review
The General Data Protection Regulation (GDPR) is a new set of EU rules governing how a company manages, protects and administers personal data. Whether you are a subscriber, author, advertiser or supplier to our journal, we may hold information about you and we need to keep it private and secure.
6 June 2018 | By Abbott Informatics
In this webinar, we’ll introduce you to laboratory information management systems (LIMS) and demonstrate how this software can help you achieve regulatory compliance, quality data management throughout your product’s lifecycle...
5 June 2018 | By European Pharmaceutical Review
The U.S. Food and Drug Administration has approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta to help reduce the risk of infection during cancer treatment.
31 May 2018 | By European Pharmaceutical Review
The FDA has accepted the NDA and granted Priority Review for larotrectinib for advanced or metastatic solid tumours harbouring a NTRK gene fusion...
28 May 2018 | By European Pharmaceutical Review
Novel enzyme therapy for adults with PKU who have uncontrolled blood phenylalanine concentrations with current treatment...
25 May 2018 | By European Pharmaceutical Review
The FDA has approved Doptelet tablets to treat low blood platelet count in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure...
24 May 2018 | By European Pharmaceutical Review
The FDA has approved the use of Prolia for the treatment of glucocorticoid-induced osteoporosis (GIOP) in men and women at high risk of fracture...
23 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
The FDA has approved Aimovig for the preventive treatment of a migraine in adults. The treatment is given by once-monthly self-injections...
16 May 2018 | By European Pharmaceutical Review
The FDA has approved Gilenya to treat relapsing multiple sclerosis in children and adolescents age 10 years and older...
15 May 2018 | By Thermo Fisher Scientific
This webinar will address some of the challenges faced by regulated and non-regulated labs as they move to cloud technology, the importance of implementing an extensible lab informatics platform solution and how digital technology has the potential to change how science is performed...
15 May 2018 | By European Pharmaceutical Review
The approval provides paediatric epilepsy patients a treatment option which can be initiated at a therapeutic dose from day one...
11 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Fast Track program is designed to facilitate development and expedite review of therapies and vaccines to address unmet health needs...
9 May 2018 | By Reading Scientific Services Limited
Reading Scientific Services Ltd (RSSL) has appointed Katarzyna Szymaniec to lead its accredited pharmaceutical training business and align its strategic development with the diverse needs of professionals working within the sector...
Follow: